The EBITDA margin stood at 25.7% in the third quarter versus 23.3% in the year-ago period. Shares of Mankind Pharma Ltd ended at ₹2,610, up by ₹94.95, or 3.78%, on the BSE.
The EBITDA margin stood at 25.7% in the third quarter versus 23.3% in the year-ago period. Shares of Mankind Pharma Ltd ended at ₹2,610, up by ₹94.95, or 3.78%, on the BSE.